Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

Abstract Background Long‐term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has a key impact on late postthrombotic complications. We hypothesize that patie...

Descrición completa

Detalles Bibliográficos

Principais autores:	Roisin Bavalia, Ingrid M. Bistervels, Wim G. Boersma, Isabelle Quere, Dominique Brisot, Nicolas Falvo, Dominique Stephan, Francis Couturaud, Sebastian Schellong, Jan Beyer‐Westendorf, Karine Montaclair, Waleed Ghanima, Marije ten Wolde, Michiel Coppens, Emile Ferrari, Olivier Sanchez, Patrick Carroll, Pierre‐Marie Roy, Susan R. Kahn, Karina Meijer, Simone Birocchi, Michael J. Kovacs, Amanda Hugman, Hugo ten Cate, Hilde Wik, Gilles Pernod, Marie‐Antoinette Sevestre‐Pietri, Michael A. Grosso, Minggao Shi, Yong Lin, Barbara A. Hutten, Peter Verhamme, Saskia Middeldorp, the Hokusai post‐PE study investigators
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2021-07-01
Series:	Research and Practice in Thrombosis and Haemostasis
Assuntos:	edoxaban pulmonary embolism quality of life warfarin
Acceso en liña:	https://doi.org/10.1002/rth2.12566
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!